Literature DB >> 21880772

Junin virus infects mouse cells and induces innate immune responses.

Christian D Cuevas1, Madakasira Lavanya, Enxiu Wang, Susan R Ross.   

Abstract

Junín virus is the causative agent for Argentine hemorrhagic fever, and its natural host is the New World rodent Calomys musculinus. The virus is transmitted to humans by aerosolization, and it is believed that many of the clinical symptoms are caused by cytokines produced by sentinel cells of the immune system. Here we used the Junín virus vaccine strain Candid 1 to determine whether mouse cells could be used to study virus entry and antiviral innate immune responses. We show that Candid 1 can infect and propagate in different mouse-derived cell lines through a low-pH-dependent, transferrin receptor 1-independent mechanism, suggesting that there is a second entry receptor. In addition, Candid 1 induced expression of the antiviral cytokines tumor necrosis factor alpha and beta interferon in macrophages, and this induction was independent of viral replication. Using Candid 1, as well as virus-like particles bearing the viral glycoprotein, to infect different primary cells and established macrophage cell lines with deletions in the Toll-like receptor (TLR) pathway, we show that TLR2 is a cellular sensor of both the Parodi and Candid 1 viral glycoproteins. Because Junín virus is highly lethal in humans, the use of an experimentally tractable model system, such as the mouse, could provide a better understanding of the antiviral innate cellular responses to Junín virus and the role of these responses in pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880772      PMCID: PMC3194972          DOI: 10.1128/JVI.05304-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Lymphocytic choriomeningitis virus (LCMV) infection of CNS glial cells results in TLR2-MyD88/Mal-dependent inflammatory responses.

Authors:  Shenghua Zhou; Annett Halle; Evelyn A Kurt-Jones; Anna M Cerny; Ermelinda Porpiglia; Michael Rogers; Douglas T Golenbock; Robert W Finberg
Journal:  J Neuroimmunol       Date:  2008-02       Impact factor: 3.478

2.  New world clade B arenaviruses can use transferrin receptor 1 (TfR1)-dependent and -independent entry pathways, and glycoproteins from human pathogenic strains are associated with the use of TfR1.

Authors:  Meg L Flanagan; Jill Oldenburg; Therese Reignier; Nathalia Holt; Genevieve A Hamilton; Vanessa K Martin; Paula M Cannon
Journal:  J Virol       Date:  2007-11-14       Impact factor: 5.103

3.  Differences in tropism and pH dependence for glycoproteins from the Clade B1 arenaviruses: implications for receptor usage and pathogenicity.

Authors:  Jill Oldenburg; Therese Reignier; Meg L Flanagan; Genevieve A Hamilton; Paula M Cannon
Journal:  Virology       Date:  2007-03-29       Impact factor: 3.616

4.  Efficient reverse genetics generation of infectious junin viruses differing in glycoprotein processing.

Authors:  César G Albariño; Eric Bergeron; Bobbie Rae Erickson; Marina L Khristova; Pierre E Rollin; Stuart T Nichol
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

5.  Glycoprotein-dependent and TLR2-independent innate immune recognition of herpes simplex virus-1 by dendritic cells.

Authors:  Adi Reske; Gabriele Pollara; Claude Krummenacher; David R Katz; Benjamin M Chain
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

Review 6.  Receptor binding and cell entry of Old World arenaviruses reveal novel aspects of virus-host interaction.

Authors:  Stefan Kunz
Journal:  Virology       Date:  2009-03-25       Impact factor: 3.616

7.  Receptor determinants of zoonotic transmission of New World hemorrhagic fever arenaviruses.

Authors:  Sheli R Radoshitzky; Jens H Kuhn; Christina F Spiropoulou; César G Albariño; Dan P Nguyen; Jorge Salazar-Bravo; Tatyana Dorfman; Amy S Lee; Enxiu Wang; Susan R Ross; Hyeryun Choe; Michael Farzan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-11       Impact factor: 11.205

8.  Host-species transferrin receptor 1 orthologs are cellular receptors for nonpathogenic new world clade B arenaviruses.

Authors:  Jonathan Abraham; Jo Ann Kwong; César G Albariño; Jiajie G Lu; Sheli R Radoshitzky; Jorge Salazar-Bravo; Michael Farzan; Christina F Spiropoulou; Hyeryun Choe
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

9.  Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection.

Authors:  Michaela Lucas; Axel Ulsenheimer; Katja Pfafferot; Malte H J Heeg; Silvana Gaudieri; Norbert Grüner; Andri Rauch; J Tilman Gerlach; Maria-Christina Jung; Reinhart Zachoval; Gerd R Pape; Winfried Schraut; Teresa Santantonio; Hans Nitschko; Martin Obermeier; Rodney Phillips; Thomas J Scriba; Nasser Semmo; Cheryl Day; Jonathan N Weber; Sarah Fidler; Robert Thimme; Anita Haberstroh; Thomas F Baumert; Paul Klenerman; Helmut M Diepolder
Journal:  PLoS One       Date:  2007-07-25       Impact factor: 3.240

Review 10.  Treatment of Argentine hemorrhagic fever.

Authors:  Delia A Enria; Ana M Briggiler; Zaida Sánchez
Journal:  Antiviral Res       Date:  2007-11-20       Impact factor: 5.970

View more
  38 in total

1.  CACNA1S haploinsufficiency confers resistance to New World arenavirus infection.

Authors:  Nicolás Sarute; Susan R Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-27       Impact factor: 11.205

2.  Pathogenic Old World arenaviruses inhibit TLR2/Mal-dependent proinflammatory cytokines in vitro.

Authors:  Melissa W Hayes; Ricardo Carrion; Jerritt Nunneley; Andrei E Medvedev; Maria S Salvato; Igor S Lukashevich
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  Toll-like receptor 2-mediated innate immune responses against Junín virus in mice lead to antiviral adaptive immune responses during systemic infection and do not affect viral replication in the brain.

Authors:  Christian D Cuevas; Susan R Ross
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

4.  MyD88-dependent immunity to a natural model of vaccinia virus infection does not involve Toll-like receptor 2.

Authors:  Michael L Davies; Janet J Sei; Nicholas A Siciliano; Ren-Huan Xu; Felicia Roscoe; Luis J Sigal; Laurence C Eisenlohr; Christopher C Norbury
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

5.  Junín Virus Promotes Autophagy To Facilitate the Virus Life Cycle.

Authors:  Julieta S Roldán; Nélida A Candurra; María I Colombo; Laura R Delgui
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

6.  Guinea Pig Transferrin Receptor 1 Mediates Cellular Entry of Junín Virus and Other Pathogenic New World Arenaviruses.

Authors:  Brady T Hickerson; Jonna B Westover; Zhongde Wang; Young-Min Lee; Brian B Gowen
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

7.  Highly Pathogenic New World and Old World Human Arenaviruses Induce Distinct Interferon Responses in Human Cells.

Authors:  Cheng Huang; Olga A Kolokoltsova; Nadezhda E Yun; Alexey V Seregin; Shannon Ronca; Takaaki Koma; Slobodan Paessler
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

8.  Computational and Functional Analysis of the Virus-Receptor Interface Reveals Host Range Trade-Offs in New World Arenaviruses.

Authors:  Scott A Kerr; Eleisha L Jackson; Oana I Lungu; Austin G Meyer; Ann Demogines; Andrew D Ellington; George Georgiou; Claus O Wilke; Sara L Sawyer
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

9.  Lassa Virus, but Not Highly Pathogenic New World Arenaviruses, Restricts Immunostimulatory Double-Stranded RNA Accumulation during Infection.

Authors:  Elizabeth J Mateer; Junki Maruyama; Galen E Card; Slobodan Paessler; Cheng Huang
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

10.  A host-oriented inhibitor of Junin Argentine hemorrhagic fever virus egress.

Authors:  Jianhong Lu; Ziying Han; Yuliang Liu; Wenbo Liu; Michael S Lee; Mark A Olson; Gordon Ruthel; Bruce D Freedman; Ronald N Harty
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.